ALIVAMAB DISCOVERY SERVICES
AlivaMab Discovery Services provides a platform for discovery and development of human therapeutic antibodies.
ALIVAMAB DISCOVERY SERVICES
Social Links:
Industry:
Biotechnology Consulting Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.alivamab.com
Total Employee:
11+
Status:
Active
Contact:
+1-858-252-3420
Email Addresses:
[email protected]
Technology used in webpage:
COVID-19 GoDaddy
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
MyMicrobiota
MyMicrobiota is a biotechnology company.
On Demand Therapeutics
On Demand Therapeutics provides an implantable device for laser-activated, on-demand release of drug therapies to the back of the eye.
ProteinLabs
ProteinLabs provides customized protein purification services and develops strategies for protein purification.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Employees Featured
Founder
Key Employee Changes
Date | New article |
---|---|
2022-01-11 | AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery |
Official Site Inspections
http://www.alivamab.com Semrush global rank: 8.51 M Semrush visits lastest month: 521
- Host name: 193.73.62.166.host.secureserver.net
- IP address: 166.62.73.193
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "AlivaMab Discovery Services"
Company AlivaMab Biologics Superior Antibody Therapeutics
Company About Us AlivaMab Biologic (AMB) sets its partnersโ antibody discovery programs on the fastest and most de-risked path through discovery and development. Trusted by top-tier โฆSee details»
AlivaMab Discovery Services - Crunchbase Company Profile
AlivaMab Mouse: A transgenic animal designed for the discovery of therapeutic antibodies, offering diversity, speed, and developability. Antibody Discovery: Platforms utilizing AlivaMab โฆSee details»
AlivaMab Biologics - Overview, News & Similar companies
View AlivaMab Biologics (www.alivamab.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
AlivaMab Discovery Services Changes Name to AlivaMab Biologics ...
Oct 16, 2023 Launching new and expanded capabilities providing end-to-end solutions in biologics discovery and engineeringSAN DIEGO, CA / ACCESSWIRE / October 16, 2023 / โฆSee details»
AlivaMab Discovery Services Changes Name to ... - AlivaMab โฆ
Launching new and expanded capabilities providing end-to-end solutions in biologics discovery and engineering SAN DIEGO, Calif. โ October 16, 2023 โ AlivaMab Discovery Services, LLC โฆSee details»
AlivaMab Biologics Company Overview, Contact Details
AlivaMab Biologics sets its partnersโ biologics programs on the path to success with the fastest and most de-risked solutions through discovery and development. Sign up for free to view info. โฆSee details»
Alivamab Discovery Services Company Profile - Craft
AlivaMab Discovery Services is a contract research organization that offers human therapeutic antibody discovery and development services. It provides solutions ranging from consulting on โฆSee details»
AlivaMab: integrated therapeutic antibody discovery solutions
Services, LLC, an AlivaMab Mouse-based contract research organization, offer customized and streamlined solutions for companies and organizations looking to obtain efficacious and โฆSee details»
AlivaMab Biologics - PitchBook
AlivaMab Biologics General Information Description. Operator of a biotechnology company intended to produce therapeutic antibodies in humans. The company uses a transgenic animal โฆSee details»
AMBโs Competitors, Revenue, Number of Employees, Funding
AMBโs Profile, Revenue and Employees. AlivaMab is a biotechnology company that offers human therapeutic antibody solutions to individuals.See details»
About - Ablexis Ablexis A superior, next generation transgenic โฆ
AlivaMab Biologics leverages the AlivaMab Mouse, developed by Ablexis as the platform for discovery projects conducted on behalf of clients. AlivaMab Biologics was established as a โฆSee details»
Larry Green, Ph.D. - Ablexis
Larry is CEO and founder of Ablexis, and co-inventor of the AlivaMab Mouse. He also serves as Chief Executive Officer of AlivaMab Biologics. Larry has over a quarter century of experience โฆSee details»
AlivaMab Discovery Services Changes Name to AlivaMab Biologics ...
Oct 16, 2023 Launching new and expanded capabilities providing end-to-end solutions in biologics discovery and engineering. SAN DIEGO, CA / ACCESSWIRE / October 16, 2023 / โฆSee details»
AlivaMab Biologics Employee Directory, Headcount & Staff | LeadIQ
Dec 11, 2024 AlivaMab Biologics provides fully integrated solutions for biologics drug discovery through our expanding platform of innovative capability modules. AMBโs customizable โฆSee details»
Integrated therapeutic antibody discovery solutions - Nature
Ablexis, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, and AlivaMab Discovery Services (ADS), a contract research โฆSee details»
Antibody Drug Discovery and the AlivaMab Mouse
Larry Green, PhD Founder and CEO of Ablexis, LLC will present on the AlivaMab Mouse Platform, an innovative, next-generation transgenic mouse platform developed by leaders in โฆSee details»
Team AlivaMab Biologics Breakthrough Drugs Begin Here
Lippy is Vice President of Research at AlivaMab Discovery Services. He has over two decades of experience in the generation and characterization of antibodies from in vivo systems. Prior to โฆSee details»
Company AlivaMab Biologics Breakthrough Drugs Begin Here
AlivaMab Discovery Services, LLC 10581 Roselle Street, Suite 115 San Diego, CA 92121 1-858-866-9310 [email protected]. Get in Touch. What We Do; Technologies; Team; Resources; โฆSee details»
Novartis intrathecal onasemnogene abeparvovec Phase III study โฆ
4 days ago The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene โฆSee details»
Team AlivaMab Biologics Superior Antibody Therapeutics
At AlivaMab Discovery Services (ADS), Mohammad is part of the antibody discovery team supporting antibody generation. Prior to joining ADS, Mohammad was a postdoctoral โฆSee details»